Search

Your search keyword '"Takahashi, Masahiro"' showing total 9 results
Start Over Author "Takahashi, Masahiro" Journal plos one
9 results on '"Takahashi, Masahiro"'

1. Preoperative prediction by artificial intelligence for mastoid extension in pars flaccida cholesteatoma using temporal bone high-resolution computed tomography: A retrospective study

Author

Takahashi, Masahiro, primary, Noda, Katsuhiko, additional, Yoshida, Kaname, additional, Tsuchida, Keisuke, additional, Yui, Ryosuke, additional, Nakazawa, Takara, additional, Kurihara, Sho, additional, Baba, Akira, additional, Motegi, Masaomi, additional, Yamamoto, Kazuhisa, additional, Yamamoto, Yutaka, additional, Ojiri, Hiroya, additional, and Kojima, Hiromi, additional

Published
2022
Full Text
View/download PDF

3. OTOF mutation analysis with massively parallel DNA sequencing in 2,265 Japanese sensorineural hearing loss patients

Author

Iwasa, Yoh-ichiro, primary, Nishio, Shin-ya, additional, Sugaya, Akiko, additional, Kataoka, Yuko, additional, Kanda, Yukihiko, additional, Taniguchi, Mirei, additional, Nagai, Kyoko, additional, Naito, Yasushi, additional, Ikezono, Tetsuo, additional, Horie, Rie, additional, Sakurai, Yuika, additional, Matsuoka, Rina, additional, Takeda, Hidehiko, additional, Abe, Satoko, additional, Kihara, Chiharu, additional, Ishino, Takashi, additional, Morita, Shin-ya, additional, Iwasaki, Satoshi, additional, Takahashi, Masahiro, additional, Ito, Tsukasa, additional, Arai, Yasuhiro, additional, and Usami, Shin-ichi, additional

Published
2019
Full Text
View/download PDF

4. WFS1 mutation screening in a large series of Japanese hearing loss patients: Massively parallel DNA sequencing-based analysis

Author

Kobayashi, Masafumi, primary, Miyagawa, Maiko, additional, Nishio, Shin-ya, additional, Moteki, Hideaki, additional, Fujikawa, Taro, additional, Ohyama, Kenji, additional, Sakaguchi, Hirofumi, additional, Miyanohara, Ikuyo, additional, Sugaya, Akiko, additional, Naito, Yasushi, additional, Morita, Shin-ya, additional, Kanda, Yukihiko, additional, Takahashi, Masahiro, additional, Ishikawa, Kotaro, additional, Nagano, Yuki, additional, Tono, Tetsuya, additional, Oshikawa, Chie, additional, Kihara, Chiharu, additional, Takahashi, Haruo, additional, Noguchi, Yoshihiro, additional, and Usami, Shin-ichi, additional

Published
2018
Full Text
View/download PDF

5. The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study

Author

Takahashi, Masahiro, primary, Takahashi, Masanobu, additional, Komine, Keigo, additional, Yamada, Hideharu, additional, Kasahara, Yuki, additional, Chikamatsu, Sonoko, additional, Okita, Akira, additional, Ito, Shukuei, additional, Ouchi, Kota, additional, Okada, Yoshinari, additional, Imai, Hiroo, additional, Saijo, Ken, additional, Shirota, Hidekazu, additional, Takahashi, Shin, additional, Mori, Takahiro, additional, Shimodaira, Hideki, additional, and Ishioka, Chikashi, additional

Published
2017
Full Text
View/download PDF

6. Efficacy and safety of gemcitabine plus docetaxel in Japanese patients with unresectable or recurrent bone and soft tissue sarcoma: Results from a single-institutional analysis

Author

Takahashi, Masanobu, primary, Komine, Keigo, additional, Imai, Hiroo, additional, Okada, Yoshinari, additional, Saijo, Ken, additional, Takahashi, Masahiro, additional, Shirota, Hidekazu, additional, Ohori, Hisatsugu, additional, Takahashi, Shin, additional, Chiba, Natsuko, additional, Mori, Takahiro, additional, Shimodaira, Hideki, additional, and Ishioka, Chikashi, additional

Published
2017
Full Text
View/download PDF

7. Contribution of FGFR1 Variants to Craniofacial Variations in East Asians

Author

Adel, Mohamed, primary, Yamaguchi, Tetsutaro, additional, Tomita, Daisuke, additional, Nakawaki, Takatoshi, additional, Kim, Yong-Il, additional, Hikita, Yu, additional, Haga, Shugo, additional, Takahashi, Masahiro, additional, Nadim, Mohamed A., additional, Kawaguchi, Akira, additional, Isa, Mutsumi, additional, El-Kenany, Walid H., additional, El-Kadi, Abbadi A., additional, Park, Soo-Byung, additional, Ishida, Hajime, additional, Maki, Koutaro, additional, and Kimura, Ryosuke, additional

Published
2017
Full Text
View/download PDF

9. The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.

Author

Shirota, Hidekazu, Mori, Takahiro, Takahashi, Masahiro, Takahashi, Masanobu, Komine, Keigo, Yamada, Hideharu, Kasahara, Yuki, Chikamatsu, Sonoko, Okita, Akira, Ito, Shukuei, Ouchi, Kota, Okada, Yoshinari, Imai, Hiroo, Saijo, Ken, Takahashi, Shin, Shimodaira, Hideki, and Ishioka, Chikashi

Subjects
CANCER patients, MEDICAL screening, GERIATRIC assessment, OLDER patients, MEDICAL needs assessment, CANCER
Abstract

Background: Some elderly cancer patients, even with good Eastern Cooperative Oncology Group performance status (ECOG-PS), have poor survival outcomes and cannot tolerate standard therapy. Few studies have detailed the associations between the G8 screening tool, ECOG-PS, and overall survival (OS) in such patients. Methods: Cancer patients, aged 70 years or older, were assessed for G8 and classified into three groups according to their G8 score: <11 as the low score group, 11–14 as the intermediate score group, and >14 as the high score group. We retrospectively analyzed the association between G8 score and OS in all patients and for each ECOG-PS-categorized group. Results: Out of 264 enrolled patients, most patients (87%) with solid tumor were categorized as TNM stage IV. ECOG-PS was 0 or 1 in 215 patients and ≥2 in 48; there was missing data for one patient. Among all patients, the low score group with a median OS of 7.7 months survived significantly less than both the high score group with a median OS of 25.6 months [Hazard ratio (HR) 3.48; 95% confidence interval (CI), 1.96–6.63; p < 0.0001] and the intermediate score group with a median of 15.6 months (HR 1.83; 95% CI, 1.28–2.65; p < 0.001). In the multivariate analysis, TNM stage and G8 score were independent prognostic factors for OS. When patients with an ECOG-PS of 0 or 1 were analyzed, patients with a lower G8 score showed significantly shorter OS than patients with a higher score when any two groups were compared. Conclusion: This novel classification of the G8 score contributes to prompt identification of patients with poor prognosis and improved the prognostic value of ECOG-PS. Using G8 with ECOG-PS may be helpful in deciding treatment for elderly patients with advanced cancer. [ABSTRACT FROM AUTHOR]

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results